25 XP   0   0   10

Insmed Inc
Buy, Hold or Sell?

Let's analyse Insmed together

PenkeI guess you are interested in Insmed Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Insmed Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Insmed Inc

I send you an email if I find something interesting about Insmed Inc.

Quick analysis of Insmed (30 sec.)










What can you expect buying and holding a share of Insmed? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-2.23
Expected worth in 1 year
$-5.06
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-2.83
Return On Investment
-11.2%

For what price can you sell your share?

Current Price per Share
$25.27
Expected price per share
$23.04 - $25.83
How sure are you?
50%

1. Valuation of Insmed (5 min.)




Live pricePrice per Share (EOD)

$25.27

Intrinsic Value Per Share

$-42.73 - $-28.62

Total Value Per Share

$-44.97 - $-30.85

2. Growth of Insmed (5 min.)




Is Insmed growing?

Current yearPrevious yearGrowGrow %
How rich?-$331.9m$55.5m-$260.9m-127.0%

How much money is Insmed making?

Current yearPrevious yearGrowGrow %
Making money-$187.3m-$120.3m-$67m-35.8%
Net Profit Margin-246.3%-197.1%--

How much money comes from the company's main activities?

3. Financial Health of Insmed (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#1004 / 1010

Most Revenue
#116 / 1010

Most Profit
#1001 / 1010

Most Efficient
#652 / 1010

What can you expect buying and holding a share of Insmed? (5 min.)

Welcome investor! Insmed's management wants to use your money to grow the business. In return you get a share of Insmed.

What can you expect buying and holding a share of Insmed?

First you should know what it really means to hold a share of Insmed. And how you can make/lose money.

Speculation

The Price per Share of Insmed is $25.27. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Insmed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Insmed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.23. Based on the TTM, the Book Value Change Per Share is $-0.71 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Insmed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.25-5.0%-1.26-5.0%-0.81-3.2%-0.75-2.9%-0.52-2.1%
Usd Book Value Change Per Share-0.29-1.1%-0.71-2.8%-0.54-2.1%-0.18-0.7%-0.08-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.29-1.1%-0.71-2.8%-0.54-2.1%-0.18-0.7%-0.08-0.3%
Usd Price Per Share30.99-23.60-21.19-25.08-21.95-
Price to Earnings Ratio-6.19--4.81--6.90--10.02--14.91-
Price-to-Total Gains Ratio-108.15--45.89--17.17--43.61--55.87-
Price to Book Ratio-13.87--25.92-5.57-4.27-8.72-
Price-to-Total Gains Ratio-108.15--45.89--17.17--43.61--55.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share25.27
Number of shares39
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.71-0.18
Usd Total Gains Per Share-0.71-0.18
Gains per Quarter (39 shares)-27.56-7.09
Gains per Year (39 shares)-110.23-28.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-110-1200-28-38
20-220-2300-57-66
30-331-3400-85-94
40-441-4500-113-122
50-551-5600-142-150
60-661-6700-170-178
70-772-7800-199-206
80-882-8900-227-234
90-992-10000-255-262
100-1102-11100-284-290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%3.095.00.03.1%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%26.069.03.026.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.098.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%26.069.03.026.5%

Fundamentals of Insmed

About Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Fundamental data was last updated by Penke on 2024-04-11 11:57:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Insmed Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Insmed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Insmed to the Biotechnology industry mean.
  • A Net Profit Margin of -222.3% means that $-2.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Insmed Inc:

  • The MRQ is -222.3%. The company is making a huge loss. -2
  • The TTM is -246.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-222.3%TTM-246.3%+24.0%
TTM-246.3%YOY-197.1%-49.2%
TTM-246.3%5Y-212.7%-33.7%
5Y-212.7%10Y-133.4%-79.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-222.3%-200.1%-22.2%
TTM-246.3%-216.8%-29.5%
YOY-197.1%-288.3%+91.2%
5Y-212.7%-449.1%+236.4%
10Y-133.4%-605.5%+472.1%
1.1.2. Return on Assets

Shows how efficient Insmed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Insmed to the Biotechnology industry mean.
  • -14.0% Return on Assets means that Insmed generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Insmed Inc:

  • The MRQ is -14.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.0%TTM-13.4%-0.6%
TTM-13.4%YOY-10.0%-3.3%
TTM-13.4%5Y-10.4%-3.0%
5Y-10.4%10Y-11.7%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.0%-13.3%-0.7%
TTM-13.4%-12.8%-0.6%
YOY-10.0%-11.7%+1.7%
5Y-10.4%-13.9%+3.5%
10Y-11.7%-15.7%+4.0%
1.1.3. Return on Equity

Shows how efficient Insmed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Insmed to the Biotechnology industry mean.
  • 0.0% Return on Equity means Insmed generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Insmed Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-119.3%+119.3%
TTM-5Y-40.4%+40.4%
5Y-40.4%10Y-30.4%-10.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-119.3%-15.1%-104.2%
5Y-40.4%-19.3%-21.1%
10Y-30.4%-20.2%-10.2%

1.2. Operating Efficiency of Insmed Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Insmed is operating .

  • Measures how much profit Insmed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Insmed to the Biotechnology industry mean.
  • An Operating Margin of -192.8% means the company generated $-1.93  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Insmed Inc:

  • The MRQ is -192.8%. The company is operating very inefficient. -2
  • The TTM is -225.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-192.8%TTM-225.3%+32.5%
TTM-225.3%YOY-193.4%-32.0%
TTM-225.3%5Y-195.7%-29.6%
5Y-195.7%10Y-125.2%-70.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-192.8%-296.2%+103.4%
TTM-225.3%-232.5%+7.2%
YOY-193.4%-298.2%+104.8%
5Y-195.7%-492.1%+296.4%
10Y-125.2%-632.4%+507.2%
1.2.2. Operating Ratio

Measures how efficient Insmed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.94 means that the operating costs are $2.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Insmed Inc:

  • The MRQ is 2.942. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.247. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.942TTM3.247-0.305
TTM3.247YOY2.934+0.314
TTM3.2475Y2.940+0.307
5Y2.94010Y1.817+1.122
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9423.231-0.289
TTM3.2473.310-0.063
YOY2.9343.890-0.956
5Y2.9405.739-2.799
10Y1.8177.876-6.059

1.3. Liquidity of Insmed Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Insmed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.12 means the company has $4.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Insmed Inc:

  • The MRQ is 4.118. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.997. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.118TTM4.997-0.879
TTM4.997YOY5.813-0.816
TTM4.9975Y6.472-1.476
5Y6.47210Y7.557-1.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1183.890+0.228
TTM4.9974.173+0.824
YOY5.8135.344+0.469
5Y6.4726.126+0.346
10Y7.5576.448+1.109
1.3.2. Quick Ratio

Measures if Insmed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Insmed to the Biotechnology industry mean.
  • A Quick Ratio of 4.96 means the company can pay off $4.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Insmed Inc:

  • The MRQ is 4.963. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.607. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.963TTM5.607-0.644
TTM5.607YOY5.953-0.345
TTM5.6075Y6.232-0.625
5Y6.23210Y7.331-1.098
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9633.514+1.449
TTM5.6073.998+1.609
YOY5.9535.380+0.573
5Y6.2326.105+0.127
10Y7.3316.404+0.927

1.4. Solvency of Insmed Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Insmed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Insmed to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.25 means that Insmed assets are financed with 125.0% credit (debt) and the remaining percentage (100% - 125.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Insmed Inc:

  • The MRQ is 1.250. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.151. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.250TTM1.151+0.098
TTM1.151YOY0.958+0.194
TTM1.1515Y0.801+0.350
5Y0.80110Y0.542+0.259
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2500.339+0.911
TTM1.1510.336+0.815
YOY0.9580.271+0.687
5Y0.8010.366+0.435
10Y0.5420.389+0.153
1.4.2. Debt to Equity Ratio

Measures if Insmed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Insmed to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Insmed Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY12.316-12.316
TTM-5Y3.554-3.554
5Y3.55410Y2.023+1.530
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM-0.402-0.402
YOY12.3160.335+11.981
5Y3.5540.426+3.128
10Y2.0230.461+1.562

2. Market Valuation of Insmed Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Insmed generates.

  • Above 15 is considered overpriced but always compare Insmed to the Biotechnology industry mean.
  • A PE ratio of -6.19 means the investor is paying $-6.19 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Insmed Inc:

  • The EOD is -5.044. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.186. Based on the earnings, the company is expensive. -2
  • The TTM is -4.813. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.044MRQ-6.186+1.142
MRQ-6.186TTM-4.813-1.373
TTM-4.813YOY-6.904+2.091
TTM-4.8135Y-10.022+5.210
5Y-10.02210Y-14.912+4.890
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.044-2.264-2.780
MRQ-6.186-2.629-3.557
TTM-4.813-2.680-2.133
YOY-6.904-4.145-2.759
5Y-10.022-6.257-3.765
10Y-14.912-6.254-8.658
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Insmed Inc:

  • The EOD is -7.058. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.655. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.440. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.058MRQ-8.655+1.598
MRQ-8.655TTM-6.440-2.215
TTM-6.440YOY-7.714+1.274
TTM-6.4405Y-11.478+5.038
5Y-11.47810Y-17.172+5.694
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.058-2.973-4.085
MRQ-8.655-3.333-5.322
TTM-6.440-3.553-2.887
YOY-7.714-5.605-2.109
5Y-11.478-8.376-3.102
10Y-17.172-8.865-8.307
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Insmed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -13.87 means the investor is paying $-13.87 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Insmed Inc:

  • The EOD is -11.310. Based on the equity, the company is expensive. -2
  • The MRQ is -13.870. Based on the equity, the company is expensive. -2
  • The TTM is -25.921. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.310MRQ-13.870+2.560
MRQ-13.870TTM-25.921+12.051
TTM-25.921YOY5.569-31.490
TTM-25.9215Y4.266-30.187
5Y4.26610Y8.717-4.450
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.3101.896-13.206
MRQ-13.8702.115-15.985
TTM-25.9212.093-28.014
YOY5.5692.884+2.685
5Y4.2663.542+0.724
10Y8.7173.916+4.801
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Insmed Inc.

3.1. Institutions holding Insmed Inc

Institutions are holding 103.186% of the shares of Insmed Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc9.51270.009614125521-219991-1.5335
2023-12-31BlackRock Inc7.73930.009111492282110159210.6017
2023-12-31T. Rowe Price Associates, Inc.7.24870.0448107637713565553.426
2023-12-31State Street Corporation3.99340.0089592993387555017.3226
2023-12-31T. Rowe Price Investment Management,Inc.3.940.11795850606-2474278-29.7215
2023-12-31Palo Alto Investors, LLC3.711815.38945511721-377770-6.4143
2023-12-31Deep Track Capital, LP3.60295.5375350000-650000-10.8333
2023-12-31FMR Inc3.42890.0121509161478666018.2734
2023-12-31Macquarie Group Ltd3.13250.16654651492-2280-0.049
2023-12-31William Blair Investment Management, LLC2.86660.38394256687147520.3478
2023-12-31Franklin Resources Inc2.28750.04923396727-15110-0.4429
2023-12-31Geode Capital Management, LLC2.0670.0130693781956816.8094
2023-12-31Suvretta Capital Management, LLC1.80783.76122684487-761847-22.106
2023-12-31Bank of New York Mellon Corp1.58720.01482356862-174857-6.9067
2023-12-31Loomis, Sayles & Company LP1.57010.11062331505-51534-2.1625
2023-12-31Bellevue Group AG1.54281.0862290958-871777-27.564
2023-12-31Ameriprise Financial Inc1.53710.0212228249140577821.6217
2023-12-31AllianceBernstein L.P.1.44650.02562147902-146894-6.4012
2023-12-31Pictet Asset Manangement SA1.32120.06711961801-451637-18.7134
2023-12-31RTW INVESTMENTS, LLC1.2560.9029186510800
Total 65.627.727897410846-2461407-2.5%

3.2. Funds holding Insmed Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-06-30BioPharma Credit Ord4.661611.0039692502469250240
2023-12-31US Small-Cap Growth II Equity Comp3.09520.57394598011-14699-0.3187
2023-12-31T. Rowe Price New Horizons3.09520.57594598011-14699-0.3187
2024-02-29Vanguard Total Stock Mkt Idx Inv3.07510.00824568279-15461-0.3373
2024-02-29Vanguard Small Cap Index2.48240.07273687698342230.9367
2024-03-28iShares Russell 2000 ETF2.27640.14013381720117360.3483
2024-03-28SPDR® S&P Biotech ETF1.84870.98672746346346401.2774
2023-12-31Macquarie US Small Cap Core Equity1.77331.0922263431100
2023-11-30Bellevue Healthcare Ord1.62436.8592412991-805594-25.0294
2024-02-29Delaware Small Cap Core I1.48490.83072205933-186735-7.8045
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.42540.0575211744515210.0719
2023-12-31T. Rowe Price Health Sciences1.39580.43682073559-123119-5.6048
2024-02-29Vanguard Small Cap Growth Index Inv1.39360.16452070322313871.5394
2023-12-31T. Rowe Price US Small-Cap Core Equity1.05930.51411573683-545100-25.727
2023-12-31T. Rowe Price Small-Cap Stock1.05930.51541573683-545100-25.727
2024-02-29Franklin Biotechnology Discv A(acc)USD0.95212.1244141440000
2024-01-31Fidelity Small Cap Index0.93870.15641394463231681.6895
2024-03-31First Trust NYSE Arca Biotech ETF0.91423.1466135803900
2024-03-28iShares Russell 2000 Growth ETF0.80740.27921199464-1395-0.1162
2023-12-31T. Rowe Price Integrated US Sm Gr Eq0.77590.4584115269300
Total 36.138829.996653686075+4809797+9.0%

3.3. Insider Transactions

Insiders are holding 1.089% of the shares of Insmed Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-12Roger AdsettSELL525128.63
2024-01-12Martina M.d. FlammerSELL466728.63
2024-01-09John Drayton WiseSELL186128.78
2024-01-09Michael Alexander SmithSELL237328.76
2024-01-09Roger AdsettSELL383729.25
2024-01-09Sara BonsteinSELL449729.18
2024-01-08William LewisSELL4512029.45
2024-01-05Roger AdsettSELL304229.21
2024-01-05William LewisSELL697929.26
2024-01-05Michael Alexander SmithSELL62729.3
2024-01-05John Drayton WiseSELL116729.32
2024-01-03John Drayton WiseSELL2007129.19
2023-12-22Martina M.d. FlammerSELL2831030
2023-12-22Sara BonsteinSELL1319930
2023-10-27William LewisSELL11200024.08
2023-07-11Michael Alexander SmithSELL74020.18
2023-06-13Martina M.d. FlammerSELL886819.27
2023-06-13Roger AdsettSELL898119.32

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Insmed Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.287-0.707+147%-0.543+89%-0.182-37%-0.080-72%
Book Value Per Share---2.234-1.383-38%0.374-698%1.131-298%1.408-259%
Current Ratio--4.1184.997-18%5.813-29%6.472-36%7.557-46%
Debt To Asset Ratio--1.2501.151+9%0.958+30%0.801+56%0.542+131%
Debt To Equity Ratio----0%12.316-100%3.554-100%2.023-100%
Dividend Per Share----0%-0%-0%-0%
Eps---1.252-1.261+1%-0.810-35%-0.745-40%-0.522-58%
Free Cash Flow Per Share---0.895-0.925+3%-0.691-23%-0.623-30%-0.439-51%
Free Cash Flow To Equity Per Share---0.065-0.641+881%0.644-110%0.095-169%0.111-159%
Gross Profit Margin--1.0001.0000%1.0030%1.0010%1.0000%
Intrinsic Value_10Y_max---28.616--------
Intrinsic Value_10Y_min---42.733--------
Intrinsic Value_1Y_max---1.920--------
Intrinsic Value_1Y_min---3.226--------
Intrinsic Value_3Y_max---6.491--------
Intrinsic Value_3Y_min---10.665--------
Intrinsic Value_5Y_max---11.933--------
Intrinsic Value_5Y_min---19.113--------
Market Cap3753985052.160-23%4603719697.9203505526801.280+31%3147137844.480+46%3725908155.648+24%3260596731.840+41%
Net Profit Margin---2.223-2.463+11%-1.971-11%-2.127-4%-1.334-40%
Operating Margin---1.928-2.253+17%-1.934+0%-1.957+1%-1.252-35%
Operating Ratio--2.9423.247-9%2.934+0%2.940+0%1.817+62%
Pb Ratio-11.310+18%-13.870-25.921+87%5.569-349%4.266-425%8.717-259%
Pe Ratio-5.044+18%-6.186-4.813-22%-6.904+12%-10.022+62%-14.912+141%
Price Per Share25.270-23%30.99023.598+31%21.185+46%25.081+24%21.949+41%
Price To Free Cash Flow Ratio-7.058+18%-8.655-6.440-26%-7.714-11%-11.478+33%-17.172+98%
Price To Total Gains Ratio-88.192+18%-108.155-45.886-58%-17.174-84%-43.608-60%-55.866-48%
Quick Ratio--4.9635.607-11%5.953-17%6.232-20%7.331-32%
Return On Assets---0.140-0.134-4%-0.100-28%-0.104-26%-0.117-16%
Return On Equity----0%-1.1930%-0.4040%-0.3040%
Total Gains Per Share---0.287-0.707+147%-0.543+89%-0.182-37%-0.080-72%
Usd Book Value---331923000.000-205419500.000-38%55528250.000-698%167991150.000-298%209187850.000-259%
Usd Book Value Change Per Share---0.287-0.707+147%-0.543+89%-0.182-37%-0.080-72%
Usd Book Value Per Share---2.234-1.383-38%0.374-698%1.131-298%1.408-259%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.252-1.261+1%-0.810-35%-0.745-40%-0.522-58%
Usd Free Cash Flow---132972000.000-137383750.000+3%-102579250.000-23%-92476500.000-30%-65244200.000-51%
Usd Free Cash Flow Per Share---0.895-0.925+3%-0.691-23%-0.623-30%-0.439-51%
Usd Free Cash Flow To Equity Per Share---0.065-0.641+881%0.644-110%0.095-169%0.111-159%
Usd Market Cap3753985052.160-23%4603719697.9203505526801.280+31%3147137844.480+46%3725908155.648+24%3260596731.840+41%
Usd Price Per Share25.270-23%30.99023.598+31%21.185+46%25.081+24%21.949+41%
Usd Profit---186061000.000-187391750.000+1%-120383500.000-35%-110709100.000-40%-77618075.000-58%
Usd Revenue--83693000.00076302000.000+10%61339500.000+36%51995350.000+61%26531050.000+215%
Usd Total Gains Per Share---0.287-0.707+147%-0.543+89%-0.182-37%-0.080-72%
 EOD+2 -6MRQTTM+21 -10YOY+12 -215Y+7 -2610Y+6 -27

4.2. Fundamental Score

Let's check the fundamental score of Insmed Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.044
Price to Book Ratio (EOD)Between0-1-11.310
Net Profit Margin (MRQ)Greater than0-2.223
Operating Margin (MRQ)Greater than0-1.928
Quick Ratio (MRQ)Greater than14.963
Current Ratio (MRQ)Greater than14.118
Debt to Asset Ratio (MRQ)Less than11.250
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.140
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Insmed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.777
Ma 20Greater thanMa 5026.754
Ma 50Greater thanMa 10027.228
Ma 100Greater thanMa 20027.863
OpenGreater thanClose25.030
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,329,837
Total Liabilities1,661,760
Total Stockholder Equity-331,923
 As reported
Total Liabilities 1,661,760
Total Stockholder Equity+ -331,923
Total Assets = 1,329,837

Assets

Total Assets1,329,837
Total Current Assets929,063
Long-term Assets400,774
Total Current Assets
Cash And Cash Equivalents 482,374
Short-term Investments 298,073
Net Receivables 41,189
Inventory 83,248
Other Current Assets 24,179
Total Current Assets  (as reported)929,063
Total Current Assets  (calculated)929,063
+/-0
Long-term Assets
Property Plant Equipment 104,386
Goodwill 136,110
Intangible Assets 63,704
Long-term Assets Other 96,574
Long-term Assets  (as reported)400,774
Long-term Assets  (calculated)400,774
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities225,629
Long-term Liabilities1,436,131
Total Stockholder Equity-331,923
Total Current Liabilities
Short-term Debt 10,642
Accounts payable 65,393
Other Current Liabilities 214,987
Total Current Liabilities  (as reported)225,629
Total Current Liabilities  (calculated)291,022
+/- 65,393
Long-term Liabilities
Long term Debt 1,155,313
Capital Lease Obligations Min Short Term Debt38,039
Long-term Liabilities Other 242,779
Long-term Liabilities  (as reported)1,436,131
Long-term Liabilities  (calculated)1,436,131
+/-0
Total Stockholder Equity
Common Stock1,480
Retained Earnings -3,446,145
Accumulated Other Comprehensive Income -745
Other Stockholders Equity 3,113,487
Total Stockholder Equity (as reported)-331,923
Total Stockholder Equity (calculated)-331,923
+/-0
Other
Capital Stock1,480
Cash and Short Term Investments 780,447
Common Stock Shares Outstanding 144,806
Current Deferred Revenue-65,393
Liabilities and Stockholders Equity 1,329,837
Net Debt 721,620
Net Invested Capital 823,390
Net Working Capital 703,434
Property Plant and Equipment Gross 149,014
Short Long Term Debt Total 1,203,994



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-06-301999-03-31
> Total Assets 
0
0
6,643
6,643
50,150
102,718
93,239
86,366
77,811
71,606
62,638
55,306
49,345
28,308
25,370
22,573
32,610
29,812
25,338
18,860
11,607
13,011
41,125
33,736
25,741
22,870
62,640
56,854
45,081
28,348
15,708
25,923
22,582
19,500
14,812
11,956
8,148
4,758
129,820
125,300
124,629
126,695
126,890
127,404
127,000
196,265
190,470
180,288
146,069
139,833
133,253
136,052
152,457
153,561
143,016
138,725
189,950
176,498
166,620
150,110
235,443
230,864
206,152
408,509
385,741
356,556
327,706
299,677
276,644
237,956
200,659
165,640
506,206
462,047
773,153
724,244
661,513
604,556
595,915
802,783
763,117
742,299
676,525
885,365
840,715
796,155
692,391
1,229,783
1,311,771
1,243,508
1,153,315
1,053,354
994,817
1,656,435
1,517,717
1,439,139
1,324,873
1,329,837
1,329,8371,324,8731,439,1391,517,7171,656,435994,8171,053,3541,153,3151,243,5081,311,7711,229,783692,391796,155840,715885,365676,525742,299763,117802,783595,915604,556661,513724,244773,153462,047506,206165,640200,659237,956276,644299,677327,706356,556385,741408,509206,152230,864235,443150,110166,620176,498189,950138,725143,016153,561152,457136,052133,253139,833146,069180,288190,470196,265127,000127,404126,890126,695124,629125,300129,8204,7588,14811,95614,81219,50022,58225,92315,70828,34845,08156,85462,64022,87025,74133,73641,12513,01111,60718,86025,33829,81232,61022,57325,37028,30849,34555,30662,63871,60677,81186,36693,239102,71850,1506,6436,64300
   > Total Current Assets 
0
0
5,470
5,470
31,405
84,620
75,465
68,899
60,585
55,049
46,199
38,981
33,772
28,151
25,243
22,474
32,534
29,751
25,291
15,526
8,274
9,681
36,156
28,930
21,093
19,203
59,525
50,733
37,484
25,423
12,675
22,963
19,669
16,973
12,467
9,690
5,961
2,593
127,684
123,202
122,537
124,608
124,805
125,319
124,900
108,797
103,062
92,619
83,983
77,399
70,960
73,850
90,353
93,578
83,025
78,566
129,745
116,163
106,209
86,712
170,843
164,714
140,243
342,089
319,258
288,118
258,490
229,310
206,296
168,407
131,624
96,534
437,480
389,444
696,413
645,258
577,495
518,946
454,632
648,914
595,604
555,194
492,510
707,312
667,149
622,892
501,004
1,038,195
958,981
837,040
756,140
674,726
632,165
1,273,383
1,129,063
1,052,424
926,576
929,063
929,063926,5761,052,4241,129,0631,273,383632,165674,726756,140837,040958,9811,038,195501,004622,892667,149707,312492,510555,194595,604648,914454,632518,946577,495645,258696,413389,444437,48096,534131,624168,407206,296229,310258,490288,118319,258342,089140,243164,714170,84386,712106,209116,163129,74578,56683,02593,57890,35373,85070,96077,39983,98392,619103,062108,797124,900125,319124,805124,608122,537123,202127,6842,5935,9619,69012,46716,97319,66922,96312,67525,42337,48450,73359,52519,20321,09328,93036,1569,6818,27415,52625,29129,75132,53422,47425,24328,15133,77238,98146,19955,04960,58568,89975,46584,62031,4055,4705,47000
       Cash And Cash Equivalents 
0
0
2,615
2,615
29,374
71,628
72,121
66,860
57,339
51,250
42,365
36,264
31,179
27,337
25,116
22,008
32,189
29,526
24,907
14,055
7,509
9,222
35,771
28,455
20,676
18,835
59,207
48,356
34,989
24,112
12,036
22,259
18,913
16,479
12,030
9,447
5,771
2,145
127,500
36,400
26,838
12,740
19,364
11,316
9,700
10,743
22,100
9,839
10,449
14,848
22,043
28,575
44,989
90,782
79,434
74,588
128,025
113,894
101,251
82,697
167,311
159,226
134,554
335,027
310,969
282,876
252,872
223,109
200,518
162,591
125,839
91,064
430,678
381,165
686,581
634,329
567,574
495,072
420,231
601,260
535,632
487,429
428,942
641,911
588,753
532,756
409,751
928,327
846,556
716,782
515,704
416,078
414,633
1,074,036
968,907
612,882
487,113
482,374
482,374487,113612,882968,9071,074,036414,633416,078515,704716,782846,556928,327409,751532,756588,753641,911428,942487,429535,632601,260420,231495,072567,574634,329686,581381,165430,67891,064125,839162,591200,518223,109252,872282,876310,969335,027134,554159,226167,31182,697101,251113,894128,02574,58879,43490,78244,98928,57522,04314,84810,4499,83922,10010,7439,70011,31619,36412,74026,83836,400127,5002,1455,7719,44712,03016,47918,91322,25912,03624,11234,98948,35659,20718,83520,67628,45535,7719,2227,50914,05524,90729,52632,18922,00825,11627,33731,17936,26442,36551,25057,33966,86072,12171,62829,3742,6152,61500
       Short-term Investments 
0
0
2,812
2,812
499
11,455
300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,222
0
0
0
285
0
0
0
407
493
493
492
12,925
7,324
8,068
3,497
252
252
86,480
95,144
109,441
103,147
113,472
114,600
97,306
80,624
82,123
72,751
61,424
48,739
44,560
44,759
2,153
2,173
2,195
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119,415
138,790
98,662
74,244
29,774
304,886
298,838
298,073
298,073298,838304,88629,77474,24498,662138,790119,41500000000000000000000000000000000002,1952,1732,15344,75944,56048,73961,42472,75182,12380,62497,306114,600113,472103,147109,44195,14486,4802522523,4978,0687,32412,9254924934934070002850009,2220000000000000030011,4554992,8122,81200
       Net Receivables 
0
0
0
0
0
0
2,760
1,264
2,863
3,521
3,659
2,266
1,733
199
199
0
0
0
0
0
0
0
0
0
0
0
0
105
250
241
111
0
25
250
327
50
72
122
114
211
319
2,268
2,212
190
200
471
169
303
440
757
757
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,515
9,347
11,638
15,346
19,232
17,154
15,173
15,196
16,562
17,628
18,417
19,317
24,351
25,722
29,481
27,401
29,713
30,523
30,947
35,579
41,189
41,18935,57930,94730,52329,71327,40129,48125,72224,35119,31718,41717,62816,56215,19615,17317,15419,23215,34611,6389,3475,515000000000000000000000000007577574403031694712001902,2122,26831921111412272503272502501112412501050000000000001991991,7332,2663,6593,5212,8631,2642,760000000
       Other Current Assets 
0
0
43
43
1,532
1,537
284
775
383
278
175
451
860
615
127
466
345
225
384
1,186
480
174
100
190
132
83
33
190
139
87
35
211
239
244
110
193
118
74
127,540
122,846
121,982
159
82
341
400
277
169
354
343
370
178
715
605
643
1,418
1,783
1,720
2,269
4,958
4,015
3,532
5,488
5,689
7,062
8,289
5,242
5,618
6,201
5,778
5,816
5,785
5,470
6,802
8,279
9,832
10,929
9,921
11,327
12,372
15,856
21,313
20,220
15,769
14,755
19,717
23,982
21,565
31,066
25,655
28,898
31,154
23,360
25,193
25,468
28,542
26,360
27,123
24,179
24,17927,12326,36028,54225,46825,19323,36031,15428,89825,65531,06621,56523,98219,71714,75515,76920,22021,31315,85612,37211,3279,92110,9299,8328,2796,8025,4705,7855,8165,7786,2015,6185,2428,2897,0625,6895,4883,5324,0154,9582,2691,7201,7831,41864360571517837034335416927740034182159121,982122,846127,54074118193110244239211358713919033831321901001744801,1863842253454661276158604511752783837752841,5371,532434300
   > Long-term Assets 
0
0
1,173
1,173
18,745
18,098
17,774
17,467
17,226
16,557
16,439
16,325
15,573
157
127
99
76
61
47
3,334
3,333
3,330
4,969
4,806
4,648
3,667
3,115
6,121
7,597
2,925
3,033
2,960
2,913
2,527
2,345
2,266
2,187
2,165
2,136
2,098
2,092
2,087
2,085
2,085
2,100
87,468
87,408
87,669
62,086
62,434
62,293
62,202
62,104
59,983
59,991
60,159
60,205
60,335
60,411
63,398
64,600
66,150
65,909
66,420
66,483
68,438
69,216
70,367
70,348
69,549
69,035
69,106
68,726
72,603
76,740
78,986
84,018
85,610
141,283
153,869
167,513
187,105
184,015
178,053
173,566
173,263
191,387
191,588
352,790
406,468
397,175
378,628
362,652
383,052
388,654
386,715
398,297
400,774
400,774398,297386,715388,654383,052362,652378,628397,175406,468352,790191,588191,387173,263173,566178,053184,015187,105167,513153,869141,28385,61084,01878,98676,74072,60368,72669,10669,03569,54970,34870,36769,21668,43866,48366,42065,90966,15064,60063,39860,41160,33560,20560,15959,99159,98362,10462,20262,29362,43462,08687,66987,40887,4682,1002,0852,0852,0872,0922,0982,1362,1652,1872,2662,3452,5272,9132,9603,0332,9257,5976,1213,1153,6674,6484,8064,9693,3303,3333,3344761769912715715,57316,32516,43916,55717,22617,46717,77418,09818,7451,1731,17300
       Property Plant Equipment 
0
0
261
261
1,702
1,628
1,513
1,415
1,382
1,172
1,054
940
188
157
127
99
76
61
47
37
30
27
24
22
20
17
15
3,029
4,513
8
7
5
4
4
4
0
0
0
0
0
0
0
0
0
0
1,102
1,042
1,016
1,424
1,937
1,867
1,758
1,647
1,666
1,681
1,855
1,904
1,812
1,977
4,778
5,982
7,534
7,292
7,989
8,052
8,092
8,899
9,793
10,274
10,020
9,807
9,234
8,975
12,432
15,816
17,881
19,526
22,636
72,542
81,229
92,940
113,109
109,671
103,263
98,422
97,233
97,027
95,616
94,007
95,516
101,767
95,171
92,811
102,082
103,729
100,930
104,734
104,386
104,386104,734100,930103,729102,08292,81195,171101,76795,51694,00795,61697,02797,23398,422103,263109,671113,10992,94081,22972,54222,63619,52617,88115,81612,4328,9759,2349,80710,02010,2749,7938,8998,0928,0527,9897,2927,5345,9824,7781,9771,8121,9041,8551,6811,6661,6471,7581,8671,9371,4241,0161,0421,10200000000004445784,5133,0291517202224273037476176991271571889401,0541,1721,3821,4151,5131,6281,70226126100
       Goodwill 
0
0
0
0
16,429
16,220
16,011
15,802
15,594
15,385
15,385
15,385
15,385
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,290
6,290
6,290
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
59,941
58,675
57,427
56,179
54,930
53,682
52,433
51,185
49,937
49,261
0
0
136,110
136,110
136,110
136,110
136,110
136,110
136,110
136,110
136,110
136,110
136,110136,110136,110136,110136,110136,110136,110136,110136,110136,1100049,26149,93751,18552,43353,68254,93056,17957,42758,67559,94158,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,2006,2906,2906,2900000000000000000000000000000000015,38515,38515,38515,38515,59415,80216,01116,22016,4290000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,043
29,551
9,764
0
0
0
0
0
0
0000009,76429,55150,04300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
12,656
16,429
16,220
16,220
0
0
15,385
15,385
15,385
15,385
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
84,190
77,900
77,900
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
58,200
59,941
58,675
57,427
56,179
54,930
53,682
52,433
51,185
49,937
49,261
47,998
46,735
75,071
73,809
72,546
71,283
70,020
68,756
67,493
66,230
64,967
63,704
63,70464,96766,23067,49368,75670,02071,28372,54673,80975,07146,73547,99849,26149,93751,18552,43353,68254,93056,17957,42758,67559,94158,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20058,20077,90077,90084,1900000000000000000000000000000000015,38515,38515,38515,3850016,22016,22016,42912,656000
       Other Assets 
0
0
912
12,756
17,043
16,470
16,261
16,052
15,844
15,385
15,385
15,385
15,385
0
0
0
0
0
0
3,297
3,303
3,303
4,945
4,784
4,628
3,650
3,100
3,092
3,084
2,917
3,026
2,955
2,909
2,523
2,345
2,266
2,187
2,165
2,136
2,098
2,092
2,087
2,085
2,085
2,085
86,366
86,366
86,653
60,662
60,497
60,426
60,444
60,457
58,317
58,310
58,304
58,301
58,523
58,434
58,620
58,618
58,616
58,617
58,431
58,431
60,346
60,317
60,574
60,074
59,529
59,228
59,872
59,751
60,171
60,924
61,105
62,751
61,287
11,314
71,024
72,994
72,453
72,837
73,319
73,708
70,049
92,438
49,237
47,602
50,990
86,801
106,314
102,512
113,692
0
118,608
0
0
00118,6080113,692102,512106,31486,80150,99047,60249,23792,43870,04973,70873,31972,83772,45372,99471,02411,31461,28762,75161,10560,92460,17159,75159,87259,22859,52960,07460,57460,31760,34658,43158,43158,61758,61658,61858,62058,43458,52358,30158,30458,31058,31760,45760,44460,42660,49760,66286,65386,36686,3662,0852,0852,0852,0872,0922,0982,1362,1652,1872,2662,3452,5232,9092,9553,0262,9173,0843,0923,1003,6504,6284,7844,9453,3033,3033,29700000015,38515,38515,38515,38515,84416,05216,26116,47017,04312,75691200
> Total Liabilities 
0
0
1,346
1,346
7,295
5,936
6,689
8,462
8,248
11,911
9,032
8,672
7,417
4,860
4,120
4,486
3,959
3,592
3,877
6,394
6,700
5,776
23,576
24,618
19,453
12,341
8,061
10,953
11,328
14,468
12,017
7,645
8,158
8,012
7,822
9,261
7,414
7,581
13,384
4,616
3,584
2,781
2,463
3,018
2,300
3,422
4,666
3,550
3,727
5,566
5,119
16,336
15,845
32,679
35,411
33,541
32,825
33,174
34,882
38,562
36,176
44,627
41,287
43,169
46,742
44,858
45,243
49,116
58,815
83,473
78,975
82,195
84,901
100,988
338,297
353,603
370,106
396,290
451,778
446,210
459,076
480,625
469,824
480,047
483,654
520,271
490,755
698,730
806,929
833,040
1,033,435
1,009,113
1,024,776
1,568,484
1,562,370
1,594,884
1,614,230
1,661,760
1,661,7601,614,2301,594,8841,562,3701,568,4841,024,7761,009,1131,033,435833,040806,929698,730490,755520,271483,654480,047469,824480,625459,076446,210451,778396,290370,106353,603338,297100,98884,90182,19578,97583,47358,81549,11645,24344,85846,74243,16941,28744,62736,17638,56234,88233,17432,82533,54135,41132,67915,84516,3365,1195,5663,7273,5504,6663,4222,3003,0182,4632,7813,5844,61613,3847,5817,4149,2617,8228,0128,1587,64512,01714,46811,32810,9538,06112,34119,45324,61823,5765,7766,7006,3943,8773,5923,9594,4864,1204,8607,4178,6729,03211,9118,2488,4626,6895,9367,2951,3461,34600
   > Total Current Liabilities 
0
0
1,346
1,346
5,462
4,138
4,927
6,736
6,558
10,256
7,413
7,089
6,465
3,892
3,213
3,664
3,221
2,946
3,307
5,763
6,030
5,048
4,147
3,938
4,019
4,870
3,405
6,076
6,226
9,681
7,010
3,150
3,828
3,682
3,870
5,698
4,377
4,877
13,384
4,616
3,584
2,781
2,463
3,018
2,300
3,339
4,463
3,492
3,682
4,477
4,136
6,486
6,545
15,747
20,272
18,101
19,822
16,456
19,998
21,818
21,278
19,630
41,125
43,067
46,698
22,259
25,543
32,320
23,458
27,989
23,271
26,272
28,766
44,656
34,806
45,642
57,419
79,732
94,252
86,030
85,392
85,240
71,532
78,754
83,902
118,807
81,397
99,656
112,501
135,166
125,249
113,816
137,654
190,243
187,984
204,257
196,728
225,629
225,629196,728204,257187,984190,243137,654113,816125,249135,166112,50199,65681,397118,80783,90278,75471,53285,24085,39286,03094,25279,73257,41945,64234,80644,65628,76626,27223,27127,98923,45832,32025,54322,25946,69843,06741,12519,63021,27821,81819,99816,45619,82218,10120,27215,7476,5456,4864,1364,4773,6823,4924,4633,3392,3003,0182,4632,7813,5844,61613,3844,8774,3775,6983,8703,6823,8283,1507,0109,6816,2266,0763,4054,8704,0193,9384,1475,0486,0305,7633,3072,9463,2213,6643,2133,8926,4657,0897,41310,2566,5586,7364,9274,1385,4621,3461,34600
       Short-term Debt 
0
0
0
0
0
0
0
0
0
4,967
3,571
0
0
2,283
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
736
1,130
1,261
1,346
1,427
1,627
1,615
1,735
574
397
208
208
0
0
81
72
64
55
114
115
117
701
3,103
4,958
4,719
7,119
3,347
5,235
3,313
5,194
24,856
24,989
25,123
25,256
3,113
5,674
8,689
0
54,791
0
55,194
55,388
55,567
302,706
307,156
0
0
9,359
9,184
11,985
12,261
11,630
8,804
10,323
12,556
7,537
7,083
7,150
10,136
9,750
5,249
5,793
8,126
8,979
6,604
8,945
10,642
10,6428,9456,6048,9798,1265,7935,2499,75010,1367,1507,0837,53712,55610,3238,80411,63012,26111,9859,1849,35900307,156302,70655,56755,38855,194054,79108,6895,6743,11325,25625,12324,98924,8565,1943,3135,2353,3477,1194,7194,9583,10370111711511455647281002082083975741,7351,6151,6271,4271,3461,2611,130736000000000000000002,283003,5714,967000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,856
0
0
0
3,113
0
8,689
0
54,791
0
55,194
55,388
55,567
302,706
307,156
0
0
9,359
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000009,35900307,156302,70655,56755,38855,194054,79108,68903,11300024,8560000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
1,144
1,144
4,632
3,391
4,262
5,836
5,372
4,427
3,241
3,197
2,706
941
1,145
1,542
638
660
1,774
3,607
3,980
2,621
1,541
1,931
1,994
968
2,243
2,884
3,784
7,187
4,251
681
736
904
804
1,088
1,117
1,277
2,667
711
581
312
433
912
400
1,450
3,082
1,921
1,504
2,334
2,879
3,198
2,985
7,060
8,184
7,865
4,661
5,929
9,818
11,407
8,867
9,249
7,860
8,681
10,857
7,468
8,688
9,402
8,283
10,439
8,454
11,030
9,348
14,671
13,176
15,966
16,579
17,741
30,223
17,031
20,415
13,184
18,188
25,005
22,147
42,853
22,422
31,081
23,531
35,784
48,571
31,144
11,576
50,461
56,670
55,699
65,377
65,393
65,39365,37755,69956,67050,46111,57631,14448,57135,78423,53131,08122,42242,85322,14725,00518,18813,18420,41517,03130,22317,74116,57915,96613,17614,6719,34811,0308,45410,4398,2839,4028,6887,46810,8578,6817,8609,2498,86711,4079,8185,9294,6617,8658,1847,0602,9853,1982,8792,3341,5041,9213,0821,4504009124333125817112,6671,2771,1171,0888049047366814,2517,1873,7842,8842,2439681,9941,9311,5412,6213,9803,6071,7746606381,5421,1459412,7063,1973,2414,4275,3725,8364,2623,3914,6321,1441,14400
       Other Current Liabilities 
0
0
202
202
830
747
522
757
1,043
719
458
3,749
3,759
358
2,068
2,122
2,583
2,286
1,533
2,156
2,050
2,427
2,606
2,007
2,025
3,902
1,162
3,192
2,442
2,494
2,759
1,320
1,361
1,272
1,449
2,358
1,442
1,515
8,647
2,958
2,272
1,731
1,421
1,536
1,802
1,256
915
1,162
1,548
2,029
988
3,019
2,708
5,584
7,130
5,517
8,042
7,180
4,945
7,098
7,217
10,381
716
701
682
683
686
716
15,175
17,550
14,817
15,242
19,418
29,985
21,630
29,676
40,840
61,991
82
234
130
280
78
44,945
51,432
63,398
51,438
61,492
81,820
89,246
66,928
77,423
120,285
131,656
122,335
197,653
187,783
214,987
214,987187,783197,653122,335131,656120,28577,42366,92889,24681,82061,49251,43863,39851,43244,945782801302348261,99140,84029,67621,63029,98519,41815,24214,81717,55015,17571668668368270171610,3817,2177,0984,9457,1808,0425,5177,1305,5842,7083,0199882,0291,5481,1629151,2561,8021,5361,4211,7312,2722,9588,6471,5151,4422,3581,4491,2721,3611,3202,7592,4942,4423,1921,1623,9022,0252,0072,6062,4272,0502,1561,5332,2862,5832,1222,0683583,7593,7494587191,04375752274783020220200
   > Long-term Liabilities 
0
0
0
0
1,833
1,798
1,762
1,726
1,690
1,655
1,619
1,583
952
968
907
822
738
646
570
631
670
728
19,429
20,680
15,434
7,471
4,656
4,877
5,102
4,787
5,007
4,495
4,330
4,330
3,952
3,563
3,037
2,704
2,704
0
0
0
1,553
1,668
1,763
83
203
58
45
1,089
983
9,850
9,300
16,932
15,139
15,440
13,003
16,718
14,884
16,744
14,898
24,997
162
102
44
22,599
19,700
16,796
35,357
55,484
55,704
55,923
56,135
56,332
303,491
307,961
312,687
316,558
357,526
360,180
373,684
395,385
398,292
401,293
399,752
401,464
409,358
599,074
694,428
697,874
908,186
895,297
887,122
1,378,241
1,374,386
1,390,627
1,417,502
1,436,131
1,436,1311,417,5021,390,6271,374,3861,378,241887,122895,297908,186697,874694,428599,074409,358401,464399,752401,293398,292395,385373,684360,180357,526316,558312,687307,961303,49156,33256,13555,92355,70455,48435,35716,79619,70022,5994410216224,99714,89816,74414,88416,71813,00315,44015,13916,9329,3009,8509831,0894558203831,7631,6681,5530002,7042,7043,0373,5633,9524,3304,3304,4955,0074,7875,1024,8774,6567,47115,43420,68019,4297286706315706467388229079689521,5831,6191,6551,6901,7261,7621,7981,8330000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,221
14,559
14,926
12,554
16,338
14,569
16,494
14,713
24,856
0
0
0
22,027
19,114
16,136
34,681
54,791
54,993
55,194
55,388
55,567
302,706
307,156
311,861
316,558
321,313
326,128
331,003
335,940
340,939
346,001
351,127
356,318
361,575
548,745
557,604
566,588
783,156
783,977
784,799
1,125,250
1,132,188
1,139,805
0
0
001,139,8051,132,1881,125,250784,799783,977783,156566,588557,604548,745361,575356,318351,127346,001340,939335,940331,003326,128321,313316,558311,861307,156302,70655,56755,38855,19454,99354,79134,68116,13619,11422,02700024,85614,71316,49414,56916,33812,55414,92614,55916,22100000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
790
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000790000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
1,833
1,798
1,762
1,726
1,690
1,655
1,619
1,583
952
968
907
822
738
646
570
631
670
728
798
866
934
1,034
1,182
1,330
1,478
1,626
1,773
1,921
2,069
2,217
2,217
2,217
2,217
2,217
0
0
0
0
0
0
0
0
132
0
0
923
852
784
717
647
580
514
449
380
315
250
185
141
162
102
44
572
586
660
676
693
711
729
747
765
785
805
826
0
504
522
11,264
10,608
10,960
11,338
10,424
9,178
9,298
12,806
100,372
95,742
81,646
69,984
63,140
60,487
0
57,561
0
0
0057,561060,48763,14069,98481,64695,742100,37212,8069,2989,17810,42411,33810,96010,60811,26452250408268057857657477297116936766605865724410216214118525031538044951458064771778485292300132000000002,2172,2172,2172,2172,2172,0691,9211,7731,6261,4781,3301,1821,0349348667987286706315706467388229079689521,5831,6191,6551,6901,7261,7621,7981,8330000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,200
0
0
0
58,200
0
0
0
58,200
0
0
0
58,200
58,200
58,200
58,200
56,988
55,776
54,563
53,351
52,139
50,926
49,714
48,501
47,289
46,076
44,864
43,651
72,039
29,600
40,014
38,801
37,588
0
35,163
0
0
0035,163037,58838,80140,01429,60072,03943,65144,86446,07647,28948,50149,71450,92652,13953,35154,56355,77656,98858,20058,20058,20058,20000058,20000058,20000058,2000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
5,297
5,297
42,855
96,782
86,550
77,904
69,563
59,695
53,606
46,634
41,928
23,448
21,250
18,087
28,651
26,220
21,461
12,466
4,907
7,235
17,549
9,118
6,288
10,529
54,579
45,901
33,753
13,880
3,691
18,278
14,424
11,488
6,990
2,695
734
-2,823
116,436
120,684
121,045
123,914
124,427
124,386
124,700
192,843
185,804
176,738
142,342
134,267
128,134
119,716
136,612
120,882
107,605
105,184
157,125
143,324
131,738
111,548
199,267
186,237
164,865
365,340
338,999
311,698
282,463
250,561
217,829
154,483
121,684
83,445
421,305
361,059
434,856
370,641
291,407
208,266
144,137
356,573
304,041
261,674
206,701
405,318
357,061
275,884
201,636
531,053
504,842
410,468
119,880
44,241
-29,959
87,951
-44,653
-155,745
-289,357
-331,923
-331,923-289,357-155,745-44,65387,951-29,95944,241119,880410,468504,842531,053201,636275,884357,061405,318206,701261,674304,041356,573144,137208,266291,407370,641434,856361,059421,30583,445121,684154,483217,829250,561282,463311,698338,999365,340164,865186,237199,267111,548131,738143,324157,125105,184107,605120,882136,612119,716128,134134,267142,342176,738185,804192,843124,700124,386124,427123,914121,045120,684116,436-2,8237342,6956,99011,48814,42418,2783,69113,88033,75345,90154,57910,5296,2889,11817,5497,2354,90712,46621,46126,22028,65118,08721,25023,44841,92846,63453,60659,69569,56377,90486,55096,78242,8555,2975,29700
   Common Stock
0
0
44
44
271
328
328
329
329
329
330
331
331
332
332
332
384
384
384
384
384
449
450
450
535
665
1,001
1,002
1,002
1,013
1,013
1,217
1,217
1,219
1,219
1,223
1,223
1,225
1,250
1,294
1,302
1,302
1,302
1,303
1,300
1,565
248
248
248
248
249
249
312
315
316
320
391
391
393
393
496
498
500
617
618
618
619
619
619
620
621
624
766
766
766
770
771
773
776
892
893
897
899
1,014
1,018
1,028
1,033
1,152
1,184
1,187
1,193
1,199
1,217
1,357
1,364
1,428
1,430
1,480
1,4801,4301,4281,3641,3571,2171,1991,1931,1871,1841,1521,0331,0281,0181,0148998978938927767737717707667667666246216206196196196186186175004984963933933913913203163153122492492482482482481,5651,3001,3031,3021,3021,3021,2941,2501,2251,2231,2231,2191,2191,2171,2171,0131,0131,0021,0021,001665535450450449384384384384384332332332331331330329329329328328271444400
   Retained Earnings Total Equity00-3,101,151-2,856,342-2,696,578-2,536,455-2,405,310-2,309,665-2,265,243-2,152,265-2,039,551-1,922,230-1,830,589-1,728,376-1,664,717-1,602,863-1,536,499-1,483,511-1,422,829-1,356,315-1,282,162-1,190,589-1,102,846-1,026,409-957,885-892,501-847,322-802,650-765,236-696,834-659,074-622,495-588,963-557,718-526,756-498,149-470,780-453,133-429,143-405,919-391,621-375,407-358,080-349,226-335,548-320,095-310,714-301,018-294,174-286,011-251,42200000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-283
-73
-6
166
3
-548
-548
-1,152
-1,152
-1,152
-1,152
-354
-354
-354
-354
-450
-450
-450
-450
-484
-484
-484
-484
-494
-494
-494
-494
-503
-503
-63
-101
-242
-507
0
-507
0
0
0
0
445
775
1,047
2,000
993
814
1,117
871
450
666
636
835
-2,882
-2,882
0
0
-3,562
-3,562
0
0
-3,324
0
0
0
-5,306
-3
12
-5
-65
-47
-42
34
-3
39
18
20
-9
30
-7
-8
-10
-47
-98
114
193
90
424
100
968
-230
-929
-1,386
756
1,083
-1,251
-2,078
-745
-745-2,078-1,2511,083756-1,386-929-23096810042490193114-98-47-10-8-730-9201839-334-42-47-65-512-3-5,306000-3,32400-3,562-3,56200-2,882-2,8828356366664508711,1178149932,0001,0477754450000-5070-507-242-101-63-503-503-494-494-494-494-484-484-484-484-450-450-450-450-354-354-354-354-1,152-1,152-1,152-1,152-548-5483166-6-73-28300
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
426,795
427,234
427,743
428,237
429,545
455,560
456,115
455,725
462,944
532,141
534,554
537,264
540,298
651,904
656,519
662,514
891,479
896,099
900,043
904,342
909,004
914,049
919,164
923,760
930,185
1,313,006
1,318,181
1,460,460
1,472,699
1,481,205
1,489,664
1,499,646
1,778,517
1,786,667
1,797,286
1,808,712
2,069,119
2,084,305
2,105,252
2,122,743
2,569,028
2,655,823
2,673,556
2,428,582
2,449,281
2,506,665
2,782,416
2,809,242
2,945,229
0
0
002,945,2292,809,2422,782,4162,506,6652,449,2812,428,5822,673,5562,655,8232,569,0282,122,7432,105,2522,084,3052,069,1191,808,7121,797,2861,786,6671,778,5171,499,6461,489,6641,481,2051,472,6991,460,4601,318,1811,313,006930,185923,760919,164914,049909,004904,342900,043896,099891,479662,514656,519651,904540,298537,264534,554532,141462,944455,725456,115455,560429,545428,237427,743427,234426,79500000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
39,310
137,413
199,644
199,505
199,651
199,681
200,329
200,346
200,480
200,480
199,698
199,709
199,786
212,696
212,812
212,812
212,828
212,865
220,999
237,076
237,169
248,010
265,016
322,157
322,389
322,614
324,167
324,231
340,675
340,773
341,270
341,403
341,771
342,480
342,378
343,817
349,622
350,125
350,243
350,308
350,372
350,100
423,877
426,146
426,795
427,234
427,743
428,237
429,545
455,560
456,115
456,515
462,944
532,141
538,116
537,264
540,298
651,904
659,843
662,514
891,479
896,099
905,349
904,342
909,004
914,049
919,164
923,760
930,185
1,313,006
1,318,181
1,460,460
1,472,699
1,481,205
1,489,664
1,499,646
1,778,517
1,786,667
1,797,286
1,808,712
2,069,119
2,084,305
2,105,252
2,122,743
2,569,028
2,655,823
2,673,556
2,428,582
2,449,281
2,506,665
2,782,416
2,809,242
2,945,229
2,971,375
3,113,487
3,113,4872,971,3752,945,2292,809,2422,782,4162,506,6652,449,2812,428,5822,673,5562,655,8232,569,0282,122,7432,105,2522,084,3052,069,1191,808,7121,797,2861,786,6671,778,5171,499,6461,489,6641,481,2051,472,6991,460,4601,318,1811,313,006930,185923,760919,164914,049909,004904,342905,349896,099891,479662,514659,843651,904540,298537,264538,116532,141462,944456,515456,115455,560429,545428,237427,743427,234426,795426,146423,877350,100350,372350,308350,243350,125349,622343,817342,378342,480341,771341,403341,270340,773340,675324,231324,167322,614322,389322,157265,016248,010237,169237,076220,999212,865212,828212,812212,812212,696199,786199,709199,698200,480200,480200,346200,329199,681199,651199,505199,644137,41339,310000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue305,208
Cost of Revenue-65,573
Gross Profit239,635239,635
 
Operating Income (+$)
Gross Profit239,635
Operating Expense-920,564
Operating Income-709,626-680,929
 
Operating Expense (+$)
Research Development571,011
Selling General Administrative344,501
Selling And Marketing Expenses0
Operating Expense920,564915,512
 
Net Interest Income (+$)
Interest Income1,882
Interest Expense-76,256
Other Finance Cost-7,320
Net Interest Income-81,694
 
Pretax Income (+$)
Operating Income-709,626
Net Interest Income-81,694
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-747,012-725,237
EBIT - interestExpense = -760,767
-747,012
-673,311
Interest Expense76,256
Earnings Before Interest and Taxes (EBIT)-684,511-670,756
Earnings Before Interest and Taxes (EBITDA)-673,932
 
After tax Income (+$)
Income Before Tax-747,012
Tax Provision-2,555
Net Income From Continuing Ops-749,567-749,567
Net Income-749,567
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses986,137
Total Other Income/Expenses Net15,61181,694
 

Technical Analysis of Insmed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Insmed. The general trend of Insmed is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Insmed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Insmed Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 25.06 < 25.52 < 25.83.

The bearish price targets are: 23.55 > 23.26 > 23.04.

Tweet this
Insmed Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Insmed Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Insmed Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Insmed Inc. The current macd is -0.63952604.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Insmed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Insmed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Insmed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Insmed Inc Daily Moving Average Convergence/Divergence (MACD) ChartInsmed Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Insmed Inc. The current adx is 23.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Insmed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Insmed Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Insmed Inc. The current sar is 27.22.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Insmed Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Insmed Inc. The current rsi is 40.78. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Insmed Inc Daily Relative Strength Index (RSI) ChartInsmed Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Insmed Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Insmed price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Insmed Inc Daily Stochastic Oscillator ChartInsmed Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Insmed Inc. The current cci is -112.71140722.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Insmed Inc Daily Commodity Channel Index (CCI) ChartInsmed Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Insmed Inc. The current cmo is -20.44821097.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Insmed Inc Daily Chande Momentum Oscillator (CMO) ChartInsmed Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Insmed Inc. The current willr is -66.21490803.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Insmed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Insmed Inc Daily Williams %R ChartInsmed Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Insmed Inc.

Insmed Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Insmed Inc. The current atr is 1.14452247.

Insmed Inc Daily Average True Range (ATR) ChartInsmed Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Insmed Inc. The current obv is 10,081,098.

Insmed Inc Daily On-Balance Volume (OBV) ChartInsmed Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Insmed Inc. The current mfi is 37.39.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Insmed Inc Daily Money Flow Index (MFI) ChartInsmed Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Insmed Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Insmed Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Insmed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.777
Ma 20Greater thanMa 5026.754
Ma 50Greater thanMa 10027.228
Ma 100Greater thanMa 20027.863
OpenGreater thanClose25.030
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Insmed with someone you think should read this too:
  • Are you bullish or bearish on Insmed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Insmed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Insmed Inc

I send you an email if I find something interesting about Insmed Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Insmed Inc.

Receive notifications about Insmed Inc in your mailbox!